Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001021771-25-000048
Filing Date
2025-02-19
Accepted
2025-02-19 16:39:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 5818
2 INCENTIVE STOCK OPTION AWARD AGREEMENT ex99_1.htm EX-99.1 51958
  Complete submission text file 0001021771-25-000048.txt   59344
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Subject) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-86699 | Film No.: 25641009
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)

Mailing Address BIORESTORATIVE THERAPIES, INC. 40 MARCUS DRIVE, SUITE 1 MELVILLE NY 11747
Business Address
ALSTODT LANCE (Filed by) CIK: 0001756228 (see all company filings)

Type: SCHEDULE 13D/A